Mutasem Rawas-Qalaji


Last quote by Mutasem Rawas-Qalaji

Due to the uniqueness and variability of severity of these life-threatening allergic reactions, it's unethical to conduct trials on patients experiencing anaphylaxis or induce anaphylactic reactions to conduct a study for EpiPill or any other alternative injectable or non-injectable dosage
share this quote
Nov 19 2016
Mutasem Rawas-Qalaji has been quoted in 1 different article. Most recently, Mutasem Rawas-Qalaji has been quoted saying, “My inspiration was a serious unmet medical need, due to children in danger, mothers afraid to treat their children, too many serious allergenic reactions and the rising costs of commonly used methods. I hope the development of this product is successful and can be registered as early as possible, to meet the needs of the patients and reduce the level of anxiety associated with the self-administration of epinephrine injections.” in an article called A pill may soon replace the costly EpiPen. This is only one of 2 quotes from Mutasem Rawas-Qalaji. To see more examples Mutasem Rawas-Qalaji’s views and opinions, check out the section below. You can filter Mutasem Rawas-Qalaji's quotes by date and by topic to see, for example, what Mutasem Rawas-Qalaji said about reaction recently and in the past.
Automatically powered by Storyzy
Take our quote verification challenge and find out !

Quotes by Mutasem Rawas-Qalaji

Quote Verifier
Check if the quote you read on social networks is authentic
This webpage has been created by a robot: errors and absent quotes cannot be totally avoided

Quote :

Mistake :

Comments :